Native Hawaiians who struggled to control their high blood pressure and type 2 diabetes benefited greatly from a six-month hula dancing program, researchers reported at the American Heart Association’s Hypertension 2019 Scientific Sessions.

Preliminary research presented at the American Heart Association’s Hypertension 2019 Scientific Sessions this week suggests gut bacteria could be an indicator of whether someone with high blood pressure also suffers from depression.

Motivational text messages could be the key to better glycemic control in patients with both diabetes mellitus and coronary heart disease, according to research out of China.

Research presented this month at the ESC Congress in Paris suggests that getting a yearly influenza shot could greatly cut hypertensive patients’ risk of dying during flu season.

Biomedical tech company Biobeat has received 510K clearance for its noninvasive, cuffless BP-monitoring systems.

Months after the latest losartan recall and more than a year after drug companies first started pulling bulk lots of angiotensin II receptor blockers (ARB) from pharmacy shelves, the FDA has issued a statement updating the American public on the scope of the situation.

Anxiety about rejection and abandonment in close relationships could be a risk factor for cardiovascular disease, a study out of Concordia University has found.

An editorial published in the latest issue of The Lancet suggests physicians might make quicker progress toward reducing global levels of uncontrolled hypertension if they reframe the condition as part of a patient’s whole health profile, rather than as an isolated disease.